Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | REGN7945 |
Trade Name | |
Synonyms | REGN-7945|REGN 7945 |
Drug Descriptions |
REGN7945 is a bispecific antibody that targets CD38 and CD28, which potentially increases T-cell activation and cytotoxicity against tumor cells (Blood (2024) 144 (Supplement 1): 3283). |
DrugClasses | CD38 Antibody 21 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Linvoseltamab + REGN7945 | Linvoseltamab REGN7945 | 0 | 1 |
REGN7945 | REGN7945 | 0 | 0 |